Vivos Therapeutics. v. Ortho-Tain

142 F.4th 1262
Court of Appeals for the Tenth Circuit·Decided July 8, 2025·No. 24-1061·Published·Cited by 2 cases

Opinion

FILED

United States Court of Appeals PUBLISH Tenth Circuit

UNITED STATES COURT OF APPEALS July 8, 2025

Christopher M. Wolpert

FOR THE TENTH CIRCUIT Clerk of Court

VIVOS THERAPEUTICS, INC., Plaintiff - Appellee, v. No. 24-1061 ORTHO-TAIN, INC.,

Defendant - Appellant.

Appeal from the United States District Court for the District of Colorado (D.C. No. 1:20-CV-01634-WJM-JPO)

Nathan I. Neff, Neff Law Group PC, Chicago, Illinois, for Defendant-Appellant.

Brenna G. Fisher (Kevin Walton with her on the briefs), Snell & Wilmer LLP, Denver, Colorado, for Plaintiff-Appellee.

Before HARTZ, TYMKOVICH, and EID, Circuit Judges.

HARTZ, Circuit Judge.

On this interlocutory appeal, Ortho-Tain, Inc. challenges, under collateral-

order jurisdiction, the district court’s denial of its motion to dismiss based in part on absolute litigation immunity and, under pendent appellate jurisdiction, several other rulings of the court. Following the law of the case established in a prior appeal in this

matter,1 we conclude that we do not have jurisdiction over the denial of immunity because it turned on a disputed factual issue. And without appellate jurisdiction to review that ruling, we cannot exercise pendent jurisdiction over the remaining interlocutory rulings. Accordingly, we dismiss this appeal for lack of jurisdiction.

I. BACKGROUND Our prior opinion in this case sets forth the factual background. See Vivos Therapeutics, Inc. v. Ortho-Tain, Inc., No. 21-1309, 2022 WL 2223141, at *1–2 (10th Cir. June 21, 2022) (Vivos I). We repeat only what is necessary to resolve this appeal.

Vivos sued Ortho-Tain in the United States District Court for the District of Colorado after Leslie Stevens, Ortho-Tain’s chief executive officer, and Nathan Neff, its attorney, sent a series of communications to Benco Dental Supply, accusing Benco of hosting seminars where Vivos misrepresented Ortho-Tain’s products as Vivos’s own products. In response to the lawsuit, Ortho-Tain sued Vivos in the United States District Court for the Northern District of Illinois.

Vivos later filed an amended complaint asserting six claims against Ortho-

Tain: Count I – False Advertising in Violation of the Lanham Act, 15 U.S.C. § 1125(a)(1); Count II – Violation of the Colorado Consumer Protection Act, Colo. Rev. Stat. § 6-1-105; Count III – Libel Per Se; Count IV – Slander Per Se; Count V –

1 Later footnotes in this opinion, however, express our doubts about the present validity of two of the statements of law in our prior unpublished opinion.

Intentional Interference with Contractual Relations; and Count VI – Declaratory Judgment that Vivos Did Not Violate the Lanham Act.

Ortho-Tain moved to dismiss the amended complaint. Among other things, it argued that Counts III, IV, and V should be dismissed because the communications underlying those claims were preliminary to and related to the Illinois litigation and therefore protected by the Colorado litigation privilege.

When the district court denied the motion, Ortho-Tain appealed. We held that we lacked jurisdiction over the denial of immunity for Neff’s communications because that denial turned in part on disputed factual questions. We did, however, assert jurisdiction over the denial of immunity for Stevens’s communications, which had been based on the purely legal ground that nonattorneys could not invoke the privilege. We held that the privilege can apply to nonattorneys and that the district court should have reviewed Stevens’s and Neff’s statements together to see whether their statements, as a whole, related to the Illinois litigation and whether that litigation was contemplated in good faith. We declined to exercise pendent jurisdiction over Ortho-Tain’s appeal of the other interlocutory rulings.

On remand the district court again denied Ortho-Tain’s motion to dismiss. See Vivos Therapeutics, Inc. v. Ortho-Tain, Inc., No. 20-cv-1634-WJM-JPO, 2024 WL 625704, at *1 (D. Colo. Feb. 14, 2024). Regarding the immunity issue, it explained that it would not “delve into the factfinding endeavor of whether the communications in spring of 2020 were made in good faith contemplation of litigation.” Id. at *3.

Ortho-Tain appealed again. Vivos has moved to dismiss the appeal for lack of jurisdiction.

II. DISCUSSION A. Law of the Case

As we stated in the opening paragraph of this opinion, the outcome of this appeal is determined by the law-of-the-case doctrine. “Under this doctrine, the decision of the appellate court establishes the law of the case and ordinarily will be followed by both the trial court on remand and the appellate court in any subsequent appeal.” Cressman v. Thompson, 798 F.3d 938, 946 (10th Cir. 2015) (internal quotation marks omitted). “We will only deviate from the law of the case (1) when the evidence in a subsequent trial is substantially different; (2) when controlling authority has subsequently made a contrary decision of the law applicable to such issues; or (3) when the decision was clearly erroneous and would work a manifest injustice.” Id. (internal quotation marks omitted). We will have occasion to address exceptions (2) and (3) in footnote 3.

B. Appellate Jurisdiction Over Immunity Claim 1. The Litigation Privilege Before addressing appellate jurisdiction, we must say a few words about the litigation privilege. Neither party disputes that we review the claim of privilege under Colorado law. Colorado has adopted the “formulation of the [litigation] privilege in [§ 586 of] the Restatement (Second) of Torts.” Killmer, Lane & Newman, LLP v. BKP, Inc., 535 P.3d 91, 96 (Colo. 2023) (internal quotation marks omitted). Section

586 provides that “[a]n attorney at law is absolutely privileged to publish defamatory matter concerning another in communications preliminary to a proposed judicial proceeding, or in the institution of, or during the course and as a part of, a judicial proceeding in which he participates as counsel.” Id. (internal quotation marks omitted).

The Colorado Court of Appeals has set forth the following elements for the privilege to apply: “(1) the statement must have some relation to the subject matter of the litigation; (2) the statement must be made in furtherance of the objective of the litigation; and (3) in the case of prelitigation statements, the proceedings must actually be contemplated in good faith.” Coomer v. Donald J. Trump for President, Inc., 552 P.3d 562, 598 (Colo. App. 2024). Elaborating on the third element, the Colorado Supreme Court has said that the privilege applies to “pre-litigation statements only if they have some relation to a proceeding that is actually contemplated in good faith. Thus, an attorney cannot make a defamatory statement and then cloak it in the privilege by subsequently filing a bad faith and meritless claim related to the otherwise tortious statement.” Killmer, 535 P.3d at 96 (citation and internal quotation marks omitted).

After reviewing the pleadings, the district court declined to make any factual finding on whether Ortho-Tain made the prelitigation statements at issue in good faith. See Vivos Therapeutics, 2024 WL 625704 at *3. It wrote:

Given that this action is at the pleading stage, and that the Court must construe the allegations in the light most favorable to Vivos, the Court declines to delve into the factfinding endeavor of whether the

communications in spring of 2020 were made in good faith contemplation of litigation. Finding that Ortho-Tain has failed to set forth a convincing basis for dismissal on this ground, the Motion [to Dismiss] is denied to the extent it seeks dismissal of the defamation and intentional interference with contractual relations claims based on litigation privilege.

Id. (footnote omitted).

Free access — add to your briefcase to read the full text and ask questions with AI

Vivos Therapeutics. v. Ortho-Tain, 142 F.4th 1262 (10th Cir. 2025).

142 F.4th 1262 (Vivos Therapeutics. v. Ortho-Tain) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related